Post-COVID-19 depression and anxiety in patients with systemic lupus erythematosus

Abstract

Objectives

This study aimed to evaluate depression and anxiety in patients with systemic lupus erythematosus (SLE) in the post-coronavirus disease-2019 (COVID-19) period and their potential association with the disease activity and related organ damage.

Patients and Methods

This is a case–control study including 120 adult Egyptian patients with SLE: sixty patients with SLE who were proven previously to be positive for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) by polymerase chain reaction (PCR) and recovered during the 3 months prior to the study were included in the case group and an equal number of age- and sex-matched patients with SLE and no evidence of SARS-CoV-2 infection were included in the control group. Patients’ clinical history was collected, and they underwent clinical evaluation, including SLE disease activity, damage assessment, and psychological assessment.

Results

The mean depression and anxiety scores were significantly higher in cases than in the control group. Both scores showed a significant positive correlation with age, disease duration, the Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for SLE (SDI), and SLE disease activity index (SLEDAI) and a significant negative correlation with education years. Hierarchical multivariate regression analyses revealed that COVID-19 infection was a predictor for severe depression and moderate-to-severe anxiety.

Conclusions

Patients with SLE, who are already vulnerable to physiological stressors, are especially predisposed to more risk of anxiety and depression when they are contracted with COVID-19 disease. Furthermore, anxiety and depression are associated with SLE activity and damage scores, and COVID-19 infection is a significant predictor for their severity. These results suggest that healthcare providers should give special attention to the mental health of SLE patients, especially during the COVID-19 pandemic.

Keywords

Systemic lupus erythematosus depression anxiety COVID-19

Get full access to this article

View all access options for this article.

References

Parks

Santos

Barbhaiya

, et al. Understanding the role of environmental factors in the development of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2017; 31: 306–320.

Ali

Sayyed

Ameer

, et al. Systemic lupus erythematosus: an overview of the disease pathology and its management. Cureus 2018; 10: e3288.

Kaul

Gordon

Crow

, et al. Systemic lupus erythematosus. Nat Rev Dis Primers 2016; 2: 1–21.

Petri

Kawata

Fernandes

, et al. Impaired health status and the effect of pain and fatigue on functioning in clinical trial patients with systemic lupus erythematosus. J Rheumatol 2013; 40: 1865–1874.

Zamora-Racaza

Azizoddin

Ishimori

, et al. Role of psychosocial reserve capacity in anxiety and depression in patients with systemic lupus erythematosus. Int J Rheum Dis 2018; 21: 850–858.

Figueiredo-Braga

Cornaby

Cortez

, et al. Depression and anxiety in systemic lupus erythematosus: the crosstalk between immunological, clinical, and psychosocial factors. Medicine (Baltimore) 2018; 97: e11376.

Zucchi

Tani

Elefante

, et al. Impact of first wave of SARS-CoV-2 infection in patients with Systemic Lupus Erythematosus: weighting the risk of infection and flare. PLoS One 2021; 16: e0245274.

Kastritis

Kitas

Vassilopoulos

, et al. Systemic autoimmune diseases, anti-rheumatic therapies, COVID-19 infection risk and patient outcomes. Rheumatol Int 2020; 40: 1353–1360.

Mathian

Mahevas

Rohmer

, et al. Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine. Ann Rheum Dis 2020; 79: 837–839.

10.

Bozzalla Cassione

Zanframundo

Biglia

, et al. COVID-19 infection in a northern-Italian cohort of systemic lupus erythematosus assessed by telemedicine. Ann Rheum Dis 2020; 7: 1382–1383.

11.

Wang

Pan

Wan

, et al. Immediate psychological responses and associated factors during the initial stage of the 2019 coronavirus disease (COVID-19) epidemic among the general population in China. Int J Environ Res Public Health 2020; 1: 1729.

12.

Santos-Ruiz

Montero-López

Ortego-Centeno

, et al. Effect of COVID-19 confinement on the mental status of patients with systemic lupus erythematosus. Med Clin (Barc) 2021; 156(8): 379–385.

13.

Hochberg

. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.

14.

Interim

CDC

. Guidance on duration of isolation and precautions for adults with COVID-19, 2021. https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html

15.

Gladman

Ibañez

Urowitz

. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29(2): 288–291.

16.

Gladman

Ginzler

Goldsmith

, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363–369.

17.

Hamilton

. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56–62.

18.

Hamilton

. The assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50–55.

19.

Pedhazur

. Multiple regression in behavioral research: an explanation and prediction. New York: Holt, Rinehrat and Winston, 1997.

20.

Zhang

Yin

, et al. Prevalence of depression and anxiety in systemic lupus erythematosus: a systematic review and meta-analysis. BMC Psychiatry 2017; 17: 70.

21.

Spihlman

Gadi

, et al. COVID-19 and systemic lupus erythematosus: focus on immune response and therapeutics. Front Immunol 2020; 11: 2861.

22.

Vabret

Britton

Gruber

, et al. Sinai immunology review project. Immunology of COVID-19: current state of the science. Immunity 2020; 52: 910–941.

23.

Salari

Hosseinian-Far

Jalali

, et al. Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis. Glob Health 2020; 16: 57.

24.

Tee

Salido

Reyes

PWC

, et al. Psychological state and associated factors during the 2019 coronavirus disease (COVID-19) pandemic among Filipinos with rheumatoid arthritis or systemic lupus erythematosus. Open Access Rheumatol 2020; 12: 215–222.

25.

Kasturi

Price

Paushkin

, et al. Impact of the first wave of the COVID-19 pandemic on systemic lupus erythematosus patients: results from a multi-center prospective cohort. Lupus 2021; 30: 1747–1755.

26.

Quartuccio

Marchi

Azzolina

, et al. Psychological effects of lockdown measures for the COVID-19 outbreak in patients with systemic lupus erythematosus. JMDH 2021; 14: 1475–1488.

27.

Weckerle

Niewold

. The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies. Clin Rev Allergy Immunol 2011; 40: 9–42.

28.

Rubio

krishfield

Kyttaris

. COVID-19 impact among patients with systemic lupus erythematosus [abstract]. Arthritis Rheumatol 2021; 73(suppl 10).

29.

Ramirez

Argolini

Bellocchi

, et al. Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year. Clin Immunol 2021; 231: 108845.

30.

Fei

Shi

Gan

, et al. Death causes and pathogens analysis of systemic lupus erythematosus during the past 26 years. Clin Rheumatol 2014; 33: 57–63.

31.

Alharthy

Faqihi

Nasim

, et al. COVID-19 in a patient with a flare of systemic lupus erythematosus: a rare case-report. Respir Med Case Rep 2020; 31: 101252.

32.

Khalid

Rogers

Fatima

, et al. A flare of systemic lupus erythematosus disease after COVID-19 infection: a case of lupus cerebritis. Cureus 2021; 13(7): e16104. doi:10.7759/cureus.16104. Available from: https://www.cureus.com/articles/61861-a-flare-of-systemic-lupus-erythematosus-disease-after-covid-19-infection-a-case-of-lupus-cerebritis

33.

Tharwat

Zohdy

. Challenges of Egyptian patients with systemic lupus erythematosus during covid-19 pandemic. Ann Rheum Dis 2021; 80: 917–917.

34.

Raghavan

Gonakoti

Asemota

, et al. A case of systemic lupus erythematosus flare triggered by severe coronavirus disease 2019. J Clin Rheumatol 2020; 26: 234–235.

35.

Kondo

Kaneko

Oshige

, et al. Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus. Ann Rheum Dis 2021; 80: e77.

36.

Hayden

Vyas-Lahar

Rella

, et al. Severe refractory thrombocytopenia in a woman positive for coronavirus disease 2019 with lupus and antiphospholipid syndrome. Lupus 2020; 29(11): 1472–1474.

37.

Fernandez-Ruiz

Paredes

Niewold

. COVID-19 in patients with systemic lupus erythematosus: lessons learned from the inflammatory disease. Transl Res 2021; 232: 13–36.

38.

Centers for Disease Control and Prevention . Coronavirus Disease 2019 (COVID-19). [Internet]. 2020. Available from: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-with-medical-conditions.html

39.

Ornell

Schuch

Sordi

, et al. Pandemic fear” and COVID-19: mental health burden and strategies. Braz J Psychiatry 2020; 42: 232–235.

40.

Bai

Liu

Zhao Y

, et al. Depressive and anxiety disorders in systemic lupus erythematosus patients without major neuropsychiatric manifestations. J Immunol Res 2016; 2016: e2829018.

41.

Shen

Tan

Feng

, et al. The correlations of disease activity, socioeconomic status, quality of life, and depression/anxiety in Chinese patients with systemic lupus erythematosus. Clin Dev Immunol 2013; 2013: 270878.

42.

Ratanasiripong

. Predictive factors of quality of life among systemic lupus erythematosus patients in Thailand: a web-based cross-sectional study. Qual Life Res 2020; 29(9): 2415–2423.

43.

Maneeton

Louthrenoo

. Prevalence and predictors of depression in patients with systemic lupus erythematosus: a cross-sectional study. Neuropsychiatr Dis Treat 2013; 9: 799–804.

44.

Khedr

Gamal

Rashad

, et al. Impact of depression on quality of life in systemic lupus erythematosus patients. Egypt J Neurol Psychiatr Neurosurg 2021; 57: 88.

45.

Moldovan

Katsaros

Carr

, et al. The Patient Reported Outcomes in Lupus (PATROL) study: role of depression in health-related quality of life in a Southern California lupus cohort. Lupus 2011; 20: 1285–1292.